These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. (11)C-choline PET/CT and multiparametric MRI in patients with biochemical relapse of prostate cancer. Garcia JR, Romera N, Cozar M, Soler M, Moragas M, Escobar M. Actas Urol Esp; 2015 May; 39(4):259-63. PubMed ID: 25454265 [Abstract] [Full Text] [Related]
5. Role of PET-CT with 18F-fluorocholine in biochemical recurrence after treatment of prostate cancer with curative intent. Puche-Sanz I, Triviño-Ibáñez E, Vázquez-Alonso F, Llamas-Elvira JM, Cózar-Olmo JM, Rodríguez-Fernández A. Actas Urol Esp; 2017 Sep; 41(7):437-444. PubMed ID: 28389027 [Abstract] [Full Text] [Related]
8. Does Choline PET/CT Change the Management of Prostate Cancer Patients With Biochemical Failure? Goldstein J, Even-Sapir E, Ben-Haim S, Saad A, Spieler B, Davidson T, Berger R, Weiss I, Appel S, Lawrence YR, Symon Z. Am J Clin Oncol; 2017 Jun; 40(3):256-259. PubMed ID: 25319322 [Abstract] [Full Text] [Related]
12. Usefulness of 18F-fluorocoline PET/CT in prostate cancer patients with biochemical recurrence: Influence of PSA kinetics and hormone therapy. Triviño-Ibáñez EM, Puche-Sanz I, Gómez-Río M, Cózar Olmo JM, Llamas-Elvira JM, Rodríguez-Fernández A. Med Clin (Barc); 2019 Jul 19; 153(2):56-62. PubMed ID: 30660434 [Abstract] [Full Text] [Related]
17. [Diagnostic performance of bone scintigraphy and (11)C-Choline PET/CT in the detection of bone metastases in patients with biochemical recurrence of prostate cancer]. Garcia JR, Moreno C, Valls E, Cozar P, Bassa P, Soler M, Alvarez-Moro FJ, Moragas M, Riera E. Rev Esp Med Nucl Imagen Mol; 2015 Jul 19; 34(3):155-61. PubMed ID: 25443648 [Abstract] [Full Text] [Related]